Outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with systemic therapy without cytoreductive nephrectomy (CN)

被引：0
|
作者：
Richey, S. L. [1 ]
Culp, S. H. [1 ]
Wood, C. G. [1 ]
Corn, P. G. [1 ]
Jonasch, E. [1 ]
Tannir, N. M. [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16035
引用
收藏
页数：2
相关论文
共 50 条
  • [21] SUNITINIB IN PATIENTS (PTS) WITH OR WITHOUT PRIOR NEPHRECTOMY IN AN EXPANDED-ACCESS STUDY OF METASTATIC RENAL CELL CARCINOMA (MRCC)
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Kee, S. H.
    Carteni, G.
    Hariharan, S.
    Gore, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 182 - 182
  • [22] PROGRESSION-FREE AND OVERALL SURVIVAL OF PATIENTS TREATED WITH PRESURGICAL SUNITINIB PRIOR TO CYTOREDUCTIVE NEPHRECTOMY (CN) IN CLEAR CELL SYNCHRONOUS METASTATIC RENAL CELL CARCINOMA (MRCC)
    Bex, Axel
    Blank, Christian
    Chowdhury, Simon
    Nichol, David
    Peters, John
    Horenblas, Simon
    O'Brien, Tim
    Sarwar, Naveed
    Haanen, John
    Powles, Thomas
    JOURNAL OF UROLOGY, 2011, 185 (04): : E709 - E710
  • [23] CABOPRE: A phase II study of cabozantinib (cabo) prior cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC)
    De Velasco, G.
    Alonso-Gordoa, T.
    Rodriguez-Moreno, J. F.
    Duran, I.
    Carretero-Gonzalez, A.
    Martin-Soberon, M.
    Gutierrez Banos, J. L.
    Guerrero-Ramos, F.
    Duenas, M.
    Castellano Gauna, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S698 - S699
  • [24] The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma
    Abhenil Mittal
    Esmail Al-Ezzi
    Xuan Li
    Brian Moloney
    Brooke Wilson
    Pavlina Spiliopoulou
    Srikala Sridhar
    Nazanin Fallah-Rad
    Peter Chung
    Robert James Hamilton
    Martin O’malley
    Aaron R. Hansen
    British Journal of Cancer, 2023, 128 : 1888 - 1896
  • [25] The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma
    Mittal, Abhenil
    Al-Ezzi, Esmail
    Li, Xuan
    Moloney, Brian
    Wilson, Brooke
    Spiliopoulou, Pavlina
    Sridhar, Srikala
    Fallah-Rad, Nazanin
    Chung, Peter
    Hamilton, Robert James
    O'malley, Martin
    Hansen, Aaron R.
    BRITISH JOURNAL OF CANCER, 2023, 128 (10) : 1888 - 1896
  • [26] Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): A propensity score-based analysis
    Bakouny, Ziad
    Xie, Wanling
    Dudani, Shaan
    Wells, Connor
    Gan, Chun Loo
    Donskov, Frede
    Shapiro, Julia
    Davis, Ian D.
    Parnis, Francis
    Ravi, Praful
    Steinharter, John A.
    Agarwal, Neeraj
    Alva, Ajjai Shivaram
    Wood, Lori
    Kapoor, Anil
    Morales, Jose Manuel Ruiz
    Kollmannsberger, Christian K.
    Beuselinck, Benoit
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [27] Cytoreductive nephrectomy in advanced or metastatic renal cell carcinoma (mRCC): In the era of targeted strategies
    Toutziaris, C.
    Lontovinis, L.
    Tsoukalas, N.
    Radopoulos, D.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 : S26 - S26
  • [28] Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy
    Hahn, Andrew W.
    Kotecha, Ritesh R.
    Viscuse, Paul V.
    Pieretti, Alberto C.
    Wiele, Andrew J.
    Jonasch, Eric
    Lee, Chung-Han
    Gao, Jianjun
    Zurita, Amado J.
    Shah, Amishi Y.
    Campbell, Matthew T.
    Sharma, Padmanee
    Motzer, Robert J.
    Russo, Paul
    Wood, Christopher G.
    Tannir, Nizar M.
    Voss, Martin H.
    Karam, Jose A.
    Hakimi, A. Ari
    Msaouel, Pavlos
    EUROPEAN UROLOGY FOCUS, 2023, 9 (05): : 734 - 741
  • [29] Metastatic renal cell carcinoma (mRCC) patients (pts) with sarcomatoid features treated with VEGF-targeted therapy
    Golshayan, A. R.
    George, S.
    Heng, D. Y.
    Elson, P.
    Wood, L.
    Garcia, J. A.
    Aydin, H.
    Zhou, M.
    Bukowski, R. M.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Cytoreductive nephrectomy in metastatic renal cell carcinoma: outcome of patients treated with a multidisciplinary, algorithm-driven approach
    Wing K. Liu
    J. M. Lam
    T. Butters
    M. Grant
    F. Jackson-Spence
    A. Bex
    T. Powles
    B. Szabados
    World Journal of Urology, 2020, 38 : 3199 - 3205
12345